Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies
Docket Number: FDA-2022-D-0745 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research This guidance describes a standards recognition program for regenerative medicine therapies (SRP-RMT) at FDA’s Center for Biologics Evaluation …